Skip to content

Clinical trials

Phase 3 Heart Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: Italy Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20072
20081
20092
20102
20112
20131
20181
20191
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Eidos Therapeutics, a BridgeBio company2
GlaxoSmithKline2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Azienda Ospedaliera San Camillo Forlanini1
Bayer1
Biosense Webster, Inc.1
CSL Behring1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases20
Cardiovascular Diseases8
Acute Coronary Syndrome4
Atherosclerosis4
Stroke4
Atrial Fibrillation3
Coronary Artery Disease3
Heart Failure3
Myocardial Infarction3
Peripheral Arterial Disease3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.